Merck’s big earnings in Q3 play second fiddle to enthusiasm for COVID pill’s potential kdunleavy Thu, 10/28/2021 – 11:15 More: Merck's big earnings in Q3 play second fiddle to enthusiasm for COVID pill's potential Source: fierce
read moreAlnylam founding CEO Maraganore steps down after pioneering RNA interference therapy aliu Thu, 10/28/2021 – 10:42 More: Alnylam founding CEO Maraganore steps down after pioneering RNA interference therapy Source: fierce
read moreUp to 50M J&J COVID doses sit idle at Emergent plant, awaiting FDA inspection: report jkeenan Thu, 10/28/2021 – 09:29 More: Up to 50M J&J COVID doses sit idle at Emergent plant, awaiting FDA inspection: report Source: fierce
read moreTakeda’s Japan plant reemerges from FDA warning letter as pharma works through pipeline setbacks aliu Thu, 10/28/2021 – 09:02 More: Takeda's Japan plant reemerges from FDA warning letter as pharma works through pipeline setbacks Source: fierce
read moreSanofi’s €10B sales target for Dupixent? The ‘megabrand’ is more than halfway there, exec says esagonowsky Thu, 10/28/2021 – 08:43 More: Sanofi's €10B sales target for Dupixent? The 'megabrand' is more than halfway there, exec says Source: fierce
read moreMed approved for the treatment of excessive daytime sleepiness associated with obstructive sleep apnoea in adults More: EMA nod for excessive daytime sleepiness med Ozawade Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals